GWM
ARMP icon

GSB Wealth Management’s Armata Pharmaceuticals ARMP Stock Holding History

GSB Wealth Management’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$324K Buy
50,000
+20,000
+67% +$183K 0.07% 188
2026
Q1 		$307K Hold
30,000
– – 0.07% 182
2025
Q4 		$188K Hold
30,000
– – 0.04% 215
2025
Q3 		$89.4K Hold
30,000
– – 0.02% 223
2025
Q2 		$57K Buy
+30,000
New +$48.6K 0.01% 227

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

GSB Wealth Management's ARMP Position: Q2 2026 in Review

GSB Wealth Management increased its Armata Pharmaceuticals (ARMP) stake by 67% in Q2 2026, buying an estimated $183K and bringing the position to 50,000 shares worth $324K. The position accounts for 0.07% of the portfolio, ranked #188.

GSB Wealth Management first reported a position in ARMP in Q2 2025 and has held it in 5 quarters since. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • GSB Wealth Management held 50,000 shares of Armata Pharmaceuticals worth $324K as of Q2 2026.
  • GSB Wealth Management bought 20,000 Armata Pharmaceuticals shares in Q2 2026, an estimated $183K.
  • Armata Pharmaceuticals made up 0.07% of GSB Wealth Management's portfolio in Q2 2026, its #188 holding.
  • GSB Wealth Management first reported a position in Armata Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on GSB Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.